KU
Kumarswamy Ummiti
Koneru Lakshmaiah Education Foundation, Slayback Pharma India LLP, KL Deemed to be University, National Institute of Technology Warangal, Gland Pharma Ltd
0000-0001-9539-2382
Employment
-
Koneru Lakshmaiah Education Foundation Research Scholar2020 - Present
-
Slayback Pharma India LLP Director2016 - Present
-
Gland Pharma Ltd Manager2014 - 2016
-
Tevapharm India Private Limited Assistant Manager2012 - 2014
-
Dr. Reddy's Laboratories (India) Assistant Manager2005 - 2012
Education
-
KL Deemed to be University Doctor of Philosophy (PhD)2020 - 2024
-
National Institute of Technology Warangal Master of Science ( M.Sc)2002 - 2004
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Identification and characterization of unknown photo-oxidation degradation components of ganciclovir by high-performance liquid chromatography and quadrupole time-of-flight mass spectrometry Save
- Identification, Isolation, Structure Characterization, and Chromatographic Separation of a New Highly Analogous Impurity of the Ubrogepant Save
- Identification and characterization of unknown oxidation degradation products of Rimegepant by HPLC and triple quadrupole mass spectrometry Save
- Development of a Stability-Indicating Purity Method for Ubrogepant Through Stress Degradation Analysis, Extraction, and Characterization of Unidentified Degradation Products Using Flash Chromatography, NMR, IR, and LC–MS Save
- Development and Validation of a Method for Trace Level Zinc Quantification in Pharmaceutical Zinc Supplements Using a Carboxyl Functional Group Packed Column and Refractive Index Detector Save
- Evaluation of effects of temperature and humidity on the secondary structure of Ganirelix in an injectable formulation and comparison with Orgalutran® using circular dichroism spectroscopy Save
- Stable pharmaceutical compositions of succinylcholine chloride Save
- Applications of Fourier Transform Infrared and UV-Visible Spectroscopy for the demonstrating sameness of Ganirelix peptide in Liquid Injection Formulation Save
- Establishment of validated stability indicating purity method based on the stress degradation behavior of gonadotropin-releasing hormone antagonist (ganirelix) in an injectable formulation using HPLC and LC-MS-QTOF Save
- LIQUID PHARMACEUTICAL COMPOSITIONS OF BACLOFEN FOR ORAL ADMINISTRATION Save